- •Acknowledgment
- •Abbreviations and Glossary
- •Contents
- •Introduction
- •1: Should You Become a VR Surgeon?
- •2.2 A Word of Caution
- •Introduction
- •3: Fundamental Rules for the VR Surgeon
- •3.4 The “What, When, How – and Why” Questions
- •3.5 Don’t Start What You Cannot Finish
- •3.6 Common Sense vs Dogma
- •3.7 Maximal Concentration During the Entire Operation
- •3.8 Make Life as Easy for Yourself as Possible
- •3.9 Under Peer Pressure: To Yield or Not to Yield
- •3.10 Referral of the Patient
- •3.11 The Rest of the Eyeball…
- •4.1 What If the Surgeon Has Tremor?
- •4.2 How Important Is Good Dexterity?
- •4.5 Combined Surgery or Cataract Surgery Separately?
- •4.7 How Much Confidence in Himself Should the VR Surgeon Have?
- •4.8 How Long Do Vitrectomies Take?
- •4.9 Was Surgery Successful?
- •5.1 The “Target” of Counseling
- •5.2 The Patient Does Not Know Most of What Is so Obvious to the Surgeon
- •5.3 Communicating with the Patient
- •5.4 Coaching vs Trying to Be Objective
- •5.5 The Ultimate Treatment Decision: “Whose Eye Is It?”
- •5.6 Which of the Two Eyes to Operate on First?
- •5.7 What if the Eye Has Two Diseases?
- •5.8 What if the Eye Has Severe Visual Loss and the Chance of Improvement with Another Surgery Is Low?
- •5.9 Empathy: The Single Most Important Component of Counseling
- •5.10 The Prognosis with the Chosen Surgical Option
- •5.11 If the Patient Chooses to Undergo Surgery
- •5.12 The Benefits of Proper Counseling
- •5.14 The Dogmas
- •6: The VR Surgeon’s Relation to His Nurse
- •7: Examination
- •8: The Indication Whether to Operate
- •8.1 The Argument in Favor of Surgery
- •8.3 The Age of the Patient
- •8.4 The Condition of the Fellow Eye
- •11: The Surgeon’s Relation to Himself
- •11.3 Self-Examination
- •Introduction
- •12.1.1 The Pump
- •12.1.1.1 Peristaltic Pump: Flow Control
- •12.1.2 The Probe
- •12.1.2.2 Port Location
- •12.1.2.3 Port Configuration and Size
- •12.1.2.4 Cut Rate
- •12.1.2.6 Probe Length
- •12.1.3 The Light Source/Pipe
- •12.1.4 The Infusion Supply
- •12.1.5 The Trocar
- •12.1.6 The Cannula
- •12.1.7 System to Inject/Extract Viscous Fluid
- •12.1.8 The Pedal
- •12.1.10 Endodiathermy Probe
- •12.1.11 The User Interface of the Vitrectomy Console
- •12.1.12 Troubleshooting
- •12.2 The Microscope
- •13: Instruments, Tools, and Their Use
- •13.2.1.1 General Concepts of Working with Squeezable Instruments
- •13.2.1.2 The Handle
- •13.2.1.3 Forceps
- •13.2.1.4 Scissors
- •13.2.2 Hybrid Instruments
- •13.2.2.2 Retractable Instruments
- •13.2.3 Non-squeezable Hand Instruments
- •13.2.3.1 Bent (Hooked, Barbed) Needle
- •13.2.3.2 Membrane Scraper
- •13.2.3.3 Spatula/Pic
- •13.2.3.4 Intraocular Magnet
- •13.3.1 Membrane Dissection (“Viscosurgery”): Viscoelastics as a Spatula
- •13.3.2 Opening a Closed Funnel
- •14: Materials and Their Use
- •14.2 Intravitreal Gas
- •14.3 Silicone Oil
- •14.3.1 Types of Silicone Oil
- •14.3.3 Complications Related to Silicone Oil Use
- •14.3.4 Complications Related to Silicone Oil Use Removal
- •14.4 PFCL
- •14.6 Sutures
- •15: Anesthesia
- •15.1 How to Decide the Type of Anesthesia
- •15.2 If Local Anesthesia Is Chosen
- •15.3 Medications If Local Anesthesia Is Used
- •16: The Surgeon at the Operating Table
- •16.1 The OR Personnel
- •16.2 The Operating Table and the Surgeon’s Chair
- •16.2.1 The Operating Table
- •16.2.2 The Surgeon’s Chair
- •16.4 The Microscope
- •16.5 The BIOM
- •16.5.1 BIOM: The Advantages
- •16.5.2 BIOM Use: Practical Information
- •16.5.3 BIOM: Setting Up for Daily Use
- •16.5.4 BIOM: Checklist
- •16.5.5 BIOM: Troubleshooting
- •16.6 The Patient
- •16.7 The Surgeon
- •16.7.2 At the Start of Vitrectomy
- •16.7.3 Staring into the Microscope
- •16.8 Music in the OR
- •16.9 The Brightness in the OR
- •16.10 The Quality of the Air in the OR
- •16.12 The Blueprint of the OR
- •16.13 The Captain in the OR
- •16.14 The Fundamental Technical Rules of Performing Intravitreal Surgery
- •Introduction
- •17.3 The Endoscope Approach (EAV)
- •17.4 Portable Systems
- •17.5 3D Viewing
- •18.1 Disinfection and Draping
- •18.2 The Monocular Patient
- •18.3 At the Conclusion of the Operation
- •19: The Speculum and Its Placement
- •19.1 General Considerations
- •19.2 Speculum Placement
- •20.3 Injecting into the Vitreous Cavity During Surgery
- •21: Sclerotomies and the Cannulas
- •21.2 Location of the Sclerotomies
- •21.2.1 Distance from the Limbus
- •21.2.2 Location in Clock Hours
- •21.2.3 In Case of a Reoperation
- •21.2.4 In Case of Scleral Thinning
- •21.3 Inserting the Cannula
- •21.4 The Order of Cannula Placement
- •21.5 If the Palpebral Opening Is Small
- •21.6 Checking the (Infusion) Cannula
- •21.6.1 Cannula Under the Choroid/Retina: Prevention
- •21.6.2 Cannula Under the Choroid/Retina: Management
- •21.6.3 Infusion Going Under the Choroid/Retina: Management
- •21.7 The Cannulas in Use
- •21.8 The Removal of the Cannulas
- •21.8.1 Hypotony: The Causes
- •21.8.2 Hypotony: The Consequences
- •21.8.3 Hypotony: Prevention
- •21.8.4 Hypotony: Postoperative Management
- •22: Illumination
- •22.1 The Light Pipe
- •22.3 Light Built into the Handheld Instruments
- •24: Using the Vitrectomy Probe
- •24.1 Removal of the Vitreous
- •24.2 Removal of Proliferative Membranes
- •24.3 Removal of the Retina
- •24.4 Removal of the Lens
- •25: Maintaining Good Visualization
- •25.1.1 The Microscope
- •25.1.2 The Contact Lens
- •25.1.3 The Corneal Surface
- •25.1.4 The Corneal Stroma
- •25.2 Internal Factors
- •25.2.2 Pupil
- •25.2.2.1 Mechanical Forces Preventing Pupil Dilation
- •25.2.2.2 Intracameral Adrenalin or Visco
- •25.2.2.4 Iris Ring
- •25.2.2.5 Iridotomy
- •25.2.3 Lens
- •25.2.3.1 Cataract
- •25.2.3.2 “Feathering”
- •25.2.3.3 “Gas Cataract”
- •25.2.3.4 “Lens Touch”
- •25.2.4.1 Phimosis of the Anterior Capsule
- •25.2.4.2 Deposit on the Anterior IOL Surface
- •25.2.4.3 Problems with the IOL Itself
- •25.2.4.4 Fluid Condensation
- •25.2.5 The Posterior Capsule
- •25.2.6 The Vitreous Cavity
- •25.2.7 Epiretinal (Subhyaloidal) Materials
- •25.2.7.1 Blood
- •25.2.8 The Surgeon’s Actions
- •25.2.9 “Chromovitrectomy”
- •26.1.1 Vitreous Macroanatomy
- •26.1.2 Vitreous Biochemistry and Its Anatomical and Functional Implications
- •26.1.3 Retinal Histology and Macroanatomy
- •26.1.4 Anterior Segment Dimensions
- •26.2 External Anatomy for the VR Surgeon
- •26.3 Physiology: What Keeps the Retina Attached?
- •26.3.1 The RPE Pump
- •26.3.3 Presence of the Vitreous Gel
- •27: The Basics of Vitreous Removal
- •27.1 The Rationale for PPV
- •27.2 How Much Vitreous to Remove?
- •27.3 Recognizing the Presence of the Vitreous Gel
- •27.3.1 Mechanical Aids
- •27.3.2 Air (Pneumovitrectomy)
- •27.3.3 Stains and Markers
- •27.4 The Sequence of Vitreous Removal
- •27.5.2 Vitrectomy Anterior to the Equator
- •27.5.3 Vitrectomy Behind the Lens
- •28: Scleral Indentation
- •28.1 The Advantages of Scleral Indentation
- •28.2 The Mechanics of Vitrectomy with Scleral Indentation
- •28.3 Internal vs External Illumination
- •28.5 External Illumination and Nurse Indentation
- •28.6 Instrumentation and Technique
- •29: Cryopexy
- •29.1 Indication in RD
- •29.2 Surgical Technique
- •29.3 Cryopexy as a Destructive Force
- •30: Endolaser
- •30.1 The Consequences of Laser Treatment
- •30.2 The Setup
- •30.3 The Technique of Endolaser Treatment
- •30.3.1 General Considerations
- •30.3.2 Panretinal Treatment
- •30.3.3 Endolaser Cerclage and Its Complications
- •30.3.4 Endolaser as a Walling-Off (Barricading) Tool
- •30.3.5 Endolaser as a Welding Tool
- •30.4 Peripheral Laser and the Beginner VR Surgeon
- •30.5 Endocyclophotocoagulation
- •30.6 Laser Cerclage at the Slit Lamp
- •31: Working With and Under Air
- •31.1.1 Attached Retina
- •31.3 The Utilization of an Air Bubble
- •32: Working with Membranes
- •32.1.1 Instrumentation and Infrastructure
- •32.1.2 Opening the ILM
- •32.1.2.1 Sharp Opening: Incision First
- •32.1.2.2 Blunt Opening: No Incision
- •The Scraper
- •32.1.3 Peeling the Membrane
- •32.1.4 The Extent of ILM Peeling
- •32.1.5 What If the ILM Cannot Be Peeled?
- •32.1.6 ILM Removal in Eyes with Detached Macula
- •32.1.6.1 Reattaching the Macula First
- •32.1.6.2 Peeling When the Macula Is Still Detached
- •32.2.2 Removal Technique
- •32.2.2.1 Staining or Not?
- •32.2.2.2 Instrumentation
- •32.2.2.3 Location of the Point of Attack
- •32.2.2.4 The Major Risks When First Grabbing an EMP
- •32.2.2.5 The Direction of Peeling: Centripetal vs Centrifugal
- •32.2.2.6 The Speed of Peeling
- •32.2.2.7 The Extent of Peeling
- •32.2.2.8 ILM Peeling
- •32.2.2.9 Completion of Surgery
- •32.3.1.1 Recognition
- •32.3.1.2 The Goals of Surgery
- •32.3.1.3 Instrumentation
- •32.3.1.4 Surgical Steps
- •32.3.1.5 Closed Funnel/Retinal Incarceration
- •32.3.1.6 ILM Removal
- •32.4 Subretinal Membranes/Strands
- •33.1 Retinectomy
- •34: Chromovitrectomy
- •34.1 Posterior Vitreous Cortex
- •34.3.1 False-Positive Staining with ICG
- •34.3.2 Injection Technique for Staining the ILM
- •34.4 Newly Formed (PVR) Membranes
- •35: Tamponades
- •35.2 Gases
- •35.2.1 General Considerations
- •35.2.3 Gas Injection into the Nonvitrectomized Eye
- •35.2.4 The Eye with Gaseous Tamponade
- •35.3.1 Indications to Use Heavier-Than-Water Liquids
- •35.3.2 Surgical Technique
- •35.3.2.1 Implantation
- •35.4 Silicone Oil
- •35.4.1 Selecting the Type of Silicone Oil to Implant
- •35.4.2 General Considerations
- •35.4.3 Indications
- •35.4.3.1 Semipermanent Tamponade
- •35.4.3.2 Permanent Tamponade
- •35.4.4 Implantation
- •35.4.5 With Silicone Oil in the Eye
- •35.4.5.1 General Considerations
- •35.4.5.2 Emulsification
- •35.4.6 Removal
- •35.4.6.1 Timing
- •35.4.6.2 Surgical Technique
- •35.5 Exchanges
- •35.6 If the Eye Is Aphakic
- •36: Submacular Hemorrhage
- •36.1 The Nonsurgical Approach: Intravitreal Gas and tPA
- •36.2 Removal of the Clot In Toto
- •36.4 The Minimalistic Surgical Approach
- •37: Subretinal Biopsy
- •38: Combined Surgery
- •38.1 Phacoemulsification
- •38.2 Lensectomy
- •38.2.1 Lens In Situ
- •38.3.1 Lens In Situ
- •38.3.2 Lens in Vitreous
- •38.4.2 No IOL Implantation
- •38.5 Capsule Removal
- •38.5.1 Indications
- •38.5.2 Surgical Technique
- •38.6.1 Advantages
- •38.6.2 Surgical Technique
- •38.6.3 Subsequent Sub/luxation of an Iris-Claw IOL
- •38.6.3.1 Subluxated Lens
- •38.6.3.2 Luxated Lens
- •39: AC Basics
- •39.1 Paracentesis
- •39.2 Iris Prolapse
- •39.3 Anterior Synechia
- •39.5 Material in the AC
- •40.2 Retinal Tear
- •40.3 Reopening of a Posterior Scleral Wound
- •40.4 Lens/IOL Trauma
- •41: Pediatric Patients
- •42: The Highly Myopic Eye
- •42.1 The Risk of RD If Cataract Surgery Is Needed
- •42.2 Vitrectomy in the Highly Myopic Eye
- •42.3 Posterior RD over a Staphyloma
- •43: Intravitreal Injections
- •Introduction
- •44: Dropped Nucleus and Dislocated IOL
- •44.1 General Considerations
- •44.1.2 Dislocated IOL
- •44.2 Surgical Technique
- •44.2.1 Dropped Nucleus
- •45: Endophthalmitis
- •45.1 General Considerations
- •45.1.1 Etiology
- •45.1.2 Clinical Diagnosis
- •45.1.3 Timing
- •45.1.4 Treatment Options and Management Philosophy
- •45.2 Surgical Technique
- •45.3 Posttraumatic Endophthalmitis
- •46: Floaters
- •46.1 General Considerations
- •46.1.1 Indication for Surgery
- •46.1.2 Timing of Surgery
- •46.2 Surgical Technique
- •47: Hyphema
- •47.1 General Considerations
- •47.1.1 The Rationale for Surgical Removal
- •47.1.2 Medical Treatment
- •47.2 Surgical Technique
- •47.2.1 Liquid Blood
- •47.2.1.1 Monomanual Technique
- •47.2.1.2 Bimanual Technique
- •47.2.2 Clotted Blood
- •48: Iris Abnormalities
- •48.1 General Considerations
- •48.1.2 Timing of Iris Reconstruction
- •48.2 Surgical Technique
- •48.2.2 Iridodialysis
- •48.2.3 Permanent Mydriasis
- •49: Macular Disorders: Edema
- •49.1 General Considerations
- •49.1.1 Etiology
- •49.1.2 Indications for Treatment: Surgical or Nonsurgical?
- •50.1 General Considerations
- •50.1.1 VMTS
- •50.1.2 Cellophane Maculopathy
- •50.1.3 Macular Pucker
- •50.1.4 Macular Hole
- •50.2.1 VMTS
- •50.2.2 Cellophane Maculopathy
- •50.2.3 Macular Pucker
- •50.2.4 Macular Hole
- •50.2.5 If Surgery Failed for a Macular Hole
- •51: Optic Pit
- •51.1 General Considerations
- •51.2 Surgical Technique
- •52.1 General Considerations
- •52.1.1 Indications
- •52.1.2 Preoperative Considerations
- •52.2 Surgical Technique
- •53.1 General Considerations
- •53.2 Surgical Technique
- •54: Retinal Detachment
- •54.1.1 RD Due to a Horseshoe or Giant Tear
- •54.1.2 RD Due to a Dialysis
- •54.1.3 RD Due to a Round Hole
- •54.1.4 RD Due to a Staphyloma
- •54.2 Additional Information About RD
- •54.2.1 History
- •54.2.3 Clinical Course
- •54.2.4 Using Laser to Prevent RD Development
- •54.2.4.1 Prophylaxis in the Affected Eye (RD, Current or Past)
- •54.2.4.2 Prophylaxis in the Fellow Eye
- •54.2.4.3 The Patient with a History of a Retinal Tear (No RD)
- •54.3 Treatment Principles
- •54.3.2 The Goals of Surgery
- •54.3.3 Prognosis
- •54.4.1 Preoperatively
- •54.4.2.1 Initial Steps
- •54.4.2.2 Creating a Chorioretinal Adhesion
- •54.4.2.3 Drainage of the Subretinal Fluid
- •54.4.2.5 Suturing
- •54.4.2.7 Adjusting the Buckle
- •54.4.2.8 Closing the Conjunctiva
- •54.4.2.9 Gas Tamponade
- •54.4.3 Major Intraoperative Complications of SB
- •54.5 Vitrectomy
- •54.5.2.3 Intraoperative Retinal Reattachment
- •54.5.2.4 Laser Retinopexy
- •54.5.2.5 Intraocular Tamponade
- •54.5.2.6 Postoperative Positioning
- •54.5.3 Follow-Up Visits
- •54.5.4 Prognosis
- •54.5.5 RD After Silicone Oil Removal
- •54.6 Pneumatic Retinopexy
- •54.6.1 General Considerations
- •54.6.2 Patient Selection
- •54.6.3 Surgical Options
- •54.6.3.1 Cryopexy, Followed by Gas Injection
- •54.6.3.2 Gas Injection, Followed by Laser
- •54.7 Reoperation
- •55: RD, Tractional and Combined
- •55.1.1 Characteristics of the RD
- •55.1.2 Management Principles
- •56: RD, Central
- •56.1 General Considerations
- •56.2 Surgical Technique
- •57: Retinoschisis
- •57.1.1 Anatomy and Pathophysiology
- •57.1.2 Prophylactic Laser Treatment
- •57.2 Surgical Technique
- •58.1 General Considerations
- •58.1.1 Treatment Options
- •58.1.2 The Vitrectomy Option
- •58.2 Surgical Technique
- •59: Scleroplasty
- •59.1 General Considerations
- •59.2 Surgical Technique
- •60: Suprachoroidal Hemorrhage
- •60.1.1 Indications for Surgery
- •60.1.2 Timing of Surgery
- •60.2 Surgical Technique
- •61: Uveitis, Posterior
- •62: Vitreous Hemorrhage
- •62.1 General Considerations
- •62.2 Surgical Technique
- •62.3 Severe Bleeding in a Young Patient
- •62.4 Rebleeding in a Vitrectomized Eye
- •63: Trauma
- •63.1 The Timing of Surgery
- •63.2 Contusion
- •63.3 Wound Toilette
- •63.5 Suturing the Sclera
- •63.6 Subluxated Lens
- •63.7 IOFB
- •63.7.2 Posterior Segment
- •63.8 Perforating Trauma and Ruptures
- •63.9 NLP and Sympathetic Ophthalmia
- •63.11 Hemorrhagic RD
- •63.12 Additional Considerations
- •64: Postoperative Care
- •Further Reading
- •Appendix
- •Part 2. Important Personal Experiences
532 |
63 Trauma |
|
|
63.7.2 Posterior Segment
The mechanical injury caused by the IOFB occurs instantly; from this viewpoint, the injury does not differ from one without a retained foreign object. What sets the IOFB trauma apart are the following:
¥Anxiety for both patient and ophthalmologist, resulting in a reßexive urge to remove the object.
¥The risk of endophthalmitis is increased:
ÐThe object had been in contact with soil before entering the eye.
ÐThe IOFB is organic.
ÐThe patient is over 50 and the lens is also injured.
¥The risk of retinal incarceration if the IOFB caused a deep impact (see Sect. 33.3 and Fig. 63.9).9
a |
b |
Fig. 63.9 An IOFB injury with deep impact. (a) Since the impact caused choroidal and subretinal hemorrhage, once the blood was irrigated, a chorioretinectomy was also performed. (b) The lesion is at the equator; therefore it was advisable to surround it with 2 rows of laser
The management depends on several factors; these are shown in Table 63.5. The use of the permanent intraocular magnet is described under Sect. 13.2.3.4.
63.8Perforating Trauma and Ruptures
The major risk, just as in the case of an IOFB with deep impact (see above), is retinal incarceration (see Table 63.6). The risk of PVR in these eyes is around 60%.
The most effective therapeutic option is prevention, which requires a prophylactic chorioretinectomy underneath the area of the (posterior) scleral rupture, around the exit wound, or surrounding the site of the deep IOFB impact (see Sect. 33.3). If
9 Involving not only the retina but also the choroid and possibly the sclera.
63.8 Perforating Trauma and Ruptures |
533 |
|
|
|
|
Table 63.5 Management of a patient with an acute IOFB injury |
|
|
Variablea |
Treatment considerations |
|
Endophthalmitis risk is high |
Immediate PPV with complete vitreous removal and |
|
|
comprehensive antibiotic treatmentb is needed |
|
Endophthalmitis risk is average |
PPV may be performed on an emergency basis or delayed |
|
|
for a few days while the patient is closely monitored |
|
|
and prophylactic antibiotic therapyc is employed |
|
IOFB intralenticular |
There is a chance that the cataract will not progress. |
|
|
Conversely, siderosis can still be caused: an individual |
|
|
decision needs to be made |
|
IOFB in vitreous, but no VH or |
The IOFB may be extracted with an intraocular magnet (if |
|
retinal damage is presentd |
ferrous) or a forceps (if nonmagnetic), under IBO |
|
|
control, without performing vitrectomy |
|
|
Conversely, if PPV is performed, it should always be at |
|
|
least subtotal; a PVD must be created unless the patient |
|
|
is a young child and it is technically impossible or very |
|
|
dangerous (see Table 41.2) |
|
The IOFB is ferrous |
There is a risk of chemical injury (siderosis); the IOFB |
|
|
should be removed unless very strong arguments can be |
|
|
made against the removale; a strong intraocular |
|
|
(permanent) magnet is the best tool to use |
|
The IOFB is made of copperf |
Urgent removal is needed to prevent chalcosis; at least |
|
|
subtotal PPV is recommended |
|
There is severe VH |
Urgent removal is needed. IOFB removal without visual |
|
|
controlg must never be attempted. Total PPV is |
|
|
recommended |
|
The IOFB is lying on the retina |
There is no need for laser around the IOFB site |
|
but there is no deep impact |
|
|
The IOFB caused a deep impact |
Chorioretinectomy is recommended (see Sect. 33.3) |
|
The IOFB is subretinal |
If the retina is detached and a break is present, the |
|
|
extraction of the IOFB should be done through the |
|
|
break |
|
|
If there is no break, a retinotomy should be prepared right |
|
|
over the IOFB; choroidal bleeding may occur if the |
|
|
IOFB is stuck to the tissue, in which case |
|
|
chorioretinectomy is needed Þrst |
|
The IOFB is surrounded by a |
The capsule must be opened with a sharp instrument Þrst so |
|
Þbrous capsule |
that the IOFB is completely free before it is removed |
|
The IOFB is very large |
In most cases a 4th sclerotomy is prepared to remove the |
|
|
IOFB. This opening is sutured and then the surgery is |
|
|
completed. If the IOFB is very large, removal of the |
|
|
entire lensh should be considered so that the IOFB can |
|
|
be extracted through a limbal wound |
|
aSee the text for more details.
bIntravitreal, periocular, systemic; steroids should also be used (see Chap. 45). cSystemic and intravitreal; (at least topical) steroids should also be used.
dThis is the only scenario where a posterior IOFB may be extracted while leaving the vitreous behind.
eThe patient refuses or is in such a poor general condition that surgery is contraindicated. fMost commonly a piece of wiring.
gBlind extraction with the external electromagnet (see the Appendix, Part 2).
hOccasionally it is possible to preserve the posterior capsule and pull the IOFB through the posterior capsulectomy.
534 |
63 Trauma |
|
|
Table 63.6 Incarceration of the retina in severe trauma |
|
Incarceration |
|
type |
Comment |
Primary |
The incarceration is direct: the surgeon catches the prolapsing retina with his |
|
needle as he closes the scleral wounda. The incarceration occurs by an |
|
inside-out mechanism; the most typical clinical examples are a posterior |
|
rupture or, less commonly, a laceration |
Secondary |
As the scleral wound is scarring over from the episclera, moderated mainly by |
|
the Þbroblasts, the process does not stop at the inner edge of the sclera but |
|
continues inside the eye, along the retinal surfaceb. The incarceration |
|
occurs by an outside-in mechanism; the most typical clinical examples are |
|
a posterior rupture or, less commonly, a laceration. Incarceration of the |
|
retina into the exit wound of a perforating injury may also have this |
|
mechanism |
Tertiary |
The injured RPE cells react with proliferation and secretion of collagen Þbers. |
|
The incarceration occurs by an inside-in mechanism; the most typical |
|
clinical examples are an IOFB injury with a deep impact or the exit wound |
|
of a perforating injury |
aHence the recommendation not to attempt suturing a wound that is very posterior (see above, Sect. 63.5): pressure exerted on the eyeball during suturing causes the prolapse or makes it more pronounced.
bMainly the inner surface and then into the vitreous (the typical appearance of PVR) but also on the outer surface (subretinal proliferation).
a closed funnel is encountered because surgery was delayed,10 a special technique is needed to deal with it (see Sect. 32.3.1.5).
63.9NLP and Sympathetic Ophthalmia
The risk of sympathetic ophthalmia is often cited as the reason why not to perform vitrectomy on an injured eye if the VA is NLP.
¥While NLP is indeed an indicator of poor outcome, it is not an absolute one; in a large series of eyes, our team11 achieved an improvement rate of 57%.12
ÐIf it is possible to suture the eye together, even loss of retinal tissue does not justify abandoning or enucleating it.
ÐAn eye with NLP vision after trauma represents an urgent indication (see Fig. 9.1); the best (in fact, only) chance of success is a vitrectomy that is done within the Þrst few days. If the cornea does not allow visualization of
10I rather often see eyes in which no surgery other than the initial wound closure was performed, even though the injury obviously had a high risk for retinal incarceration and thus PVR development. This always causes astonishment and anger on my part; what was the original ophthalmologist hoping to achieve by waiting (ÒobservationÓ)?
11Includes Robert Morris, MD, and C. Douglas Witherspoon, MD.
12The Þnal function ranged from LP to reading vision.
63.10 TKP-PPV |
535 |
|
|
the deeper structures, deferring surgery is not an option. Either the endoscope may have to be utilized (EAV, see Sect. 17.3) or TKP is indicated (see below).
¥Citing the risk of, and fear from, sympathetic ophthalmia to justify primary or early secondary13 enucleation is absolutely unacceptable.
ÐThe patient must be properly informed that sympathetic ophthalmia, however rarely, may occur after severe trauma.14 Based on proper counseling, the patient should make the decision whether enucleation or reconstruction should be done.15
ÐIf the patient chooses reconstruction, the signs and symptoms of sympathetic ophthalmia must be explained so that treatment can immediately be initiated.
63.10 TKP-PPV
This is a very complex surgery and only an experienced VR surgeon should undertake it. Often an improper wound closure, not the presence of the wound itself, is the reason why the cornea needs to be replaced (see Table 45.2 for the options if the visualization is poor). Only a few comments are made here about the surgery:
¥Ideally, it is the VR surgeon who does the entire surgery, including removal of the damaged cornea and suturing the graft at the end of the procedure.
¥The trephine chosen to cut the cornea should be ½ mm greater than the barrel of the TKP, irrespective of its type.
ÐInsertion of the TKP into the eye with low IOP is easier if the Þt is not tight. The sutures will hold it in place without leakage.16
¥The time when the eye is open should be as short as possible (see Fig. 62.1).
¥The full armamentarium of VR surgery is likely to be needed.
ÐThe lens either has been lost during the injury or needs to be surgically removed.
ÐThe iris should not be reconstructed at this point as further surgeries are likely to be necessary (see Sect. 48.1.2).
13During the Þrst few days or weeks. Late enucleation of a blind, painful, or cosmetically disturbing eye is of course acceptable. Remember, enucleation is an amputation, with severe psychological implications for the patient.
14The risk is less than 1 in 2Ð3,000 cases; conversely, sympathetic ophthalmia can also occur after routine elective surgery.
15The key word is proper. A patient who is frightened by the information his ophthalmologist told him (because he does not want to dedicate the time and effort to operate on the injured eye) will obviously choose enucleation. A patient who is given truthful, factual information (which includes the risks and beneÞts of both enucleation and surgery as well as the prognosis with proper treatment should sympathetic ophthalmia occur) will choose reconstruction.
16A tiny amount of leakage is also not a problem; the IOP will still be maintained throughout the procedure.
- #28.03.202639.38 Mб0The Wills eye manual office and emergency room diagnosis and treatment of eye disease Adam T. Gerstenblith, Michael P. Rabinowitz.chm
- #
- #
- #
- #
- #
- #
- #28.03.202614.01 Кб0[Офтальмология] Jack J. Kanski Джек Дж. Кански - Клиническая офтальмология систематизированный подход [2006, PDF DjVu, RUS] [rutracker-5395873].torrent
- #
- #
- #
